Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Mar 25:6:22.
doi: 10.1186/1756-8722-6-22.

Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium

Affiliations

Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium

Yiying Wang et al. J Hematol Oncol. .

Abstract

Lynch syndrome (LS), an autosomal dominant inherited cancer susceptibility syndrome, also known as hereditary non-polyposis colon cancer (HNPCC), is caused by a germline mutation in one of several DNA mismatch repair (MMR) genes. LS is the most common presentation of hereditary colorectal cancer (CRC), accounting for about 2-5% of all CRC cases. More recently, it is found that a similar number of endometrial cancers is also due to one of the MMR gene mutations. There has been significant progress in LS-related CRC in terms of molecular pathogenesis, risks, genetic basis, and cancer prevention. In contrast, the advance about LS-related endometrial cancer (EC) is very much limited. In this commentary, we summarize the main clinicopathologic features of LS-related EC and propose universal screening for LS in individuals with endometrial cancer.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Algorithm of screening patients with endometrial cancer for Lynch syndrome. This algorithm does not cover the rare finding of Cowden’s Syndrome. Referral to the genetics counselor can always be made in any situation where the clinicopathologic suspicion is strong for Lynch syndrome.

References

    1. Aaltonen L, Johns L, Jarvinen H, Mecklin JP, Houlston R. Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res. 2007;13:356–361. doi: 10.1158/1078-0432.CCR-06-1256. - DOI - PubMed
    1. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919–932. doi: 10.1056/NEJMra012242. - DOI - PubMed
    1. Geiersbach KB, Samowitz WS. Microsatellite instability and colorectal cancer. Arch Pathol Lab Med. 2011;135:1269–1277. doi: 10.5858/arpa.2011-0035-RA. - DOI - PubMed
    1. Lu KH, Dinh M, Kohlmann W, Watson P, Green J, Syngal S, Bandipalliam P, Chen LM, Allen B, Conrad P, Terdiman J, Sun C, Daniels M, Burke T, Gershenson DM, Lynch H, Lynch P, Broaddus RR. Gynecologic cancer as a “sentinel cancer” for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol. 2005;105:569–574. doi: 10.1097/01.AOG.0000154885.44002.ae. - DOI - PubMed
    1. Banno K, Yanokura M, Kobayashi Y, Kawaguchi M, Nomura H, Hirasawa A, Susumu N, Aoki D. Endometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review) Curr Genomics. 2009;10:127–132. doi: 10.2174/138920209787847069. - DOI - PMC - PubMed

MeSH terms